Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring
Rim Bayaa(Lebanese University), Rossana Arenas(Ministerio de Salud Pública y Bienestar Social), Samanta Biswas(International Centre for Diarrhoeal Disease Research), Monzer Hamzé(Lebanese University), Mohammad Khaja Mafij Uddin(International Centre for Diarrhoeal Disease Research), Graciela Russomando(Instituto de Investigaciones en Ciencias de la Salud), Nestani Tukvadze(National Center for Tuberculosis and Lung Disease), Carole Chedid(Inserm), Mame Diarra Ndiaye(Institut Pasteur de Madagascar), Sayera Banu(International Centre for Diarrhoeal Disease Research), Mohamad Bachar Ismail(Lebanese University), Antso Hasina Raherinandrasana(University of Antananarivo), Hubert P. Endtz(Erasmus MC), Voahangy Rasolofo(Institut Pasteur), Jonathan Hoffmann(Inserm), Delia Goletti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Florence Ader(Université Claude Bernard Lyon 1), Giovanni Delogu(Università Cattolica del Sacro Cuore), Chyntia Carolina Díaz Acosta(Instituto de Investigaciones en Ciencias de la Salud), Eka Kokhreidze(National Center for Tuberculosis and Lung Disease), Paulo Ranaivomanana(Institut Pasteur de Madagascar), Rumana Nasrin(International Centre for Diarrhoeal Disease Research), Stéphane Pouzol(Fondation Mérieux), Niaina Rakotosamimanana(Institut Pasteur de Madagascar), Julio Rakotonirina(University of Antananarivo), Flavio De Maio(Università Cattolica del Sacro Cuore)
Cited by 39
Related Papers
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
|The Lancet|2019|923
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
|Nature|2001|464
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
|Journal of Infection|2020|445